ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,990.16
-0.14%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Akorn Inc (AKRX)

  7. Akorn Inc (AKRX) Noticias

AKRX

Akorn (AKRX)

Akorn Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AKRX
FechaHoraFuenteTítuloSímboloCompañía
26/05/202015:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKRXAkorn Inc
20/05/202022:52PR Newswire (US)Akorn to Use Voluntary Chapter 11 Process to Position Business for Long-Term SuccessNASDAQ:AKRXAkorn Inc
11/05/202016:14GlobeNewswire Inc.Akorn Provides First Quarter 2020 ResultsNASDAQ:AKRXAkorn Inc
11/05/202015:56Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AKRXAkorn Inc
08/05/202010:00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AKRXAkorn Inc
27/04/202017:17PR Newswire (US)Enphase Energy and Paylocity Set to Join S&P MidCap 400; Core Laboratories and Meredith to Join S&P SmallCap 600NASDAQ:AKRXAkorn Inc
24/04/202016:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AKRXAkorn Inc
21/04/202005:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AKRXAkorn Inc
10/04/202016:08Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:AKRXAkorn Inc
01/04/202016:08Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:AKRXAkorn Inc
01/04/202005:20PR Newswire (US)Akorn Provides Update on Sale ProcessNASDAQ:AKRXAkorn Inc
18/03/202010:40Edgar (US Regulatory)Unknown (sec Staff)NASDAQ:AKRXAkorn Inc
16/03/202015:11Edgar (US Regulatory)Amended Application for Qualification of Trust Indentures (t-3/a)NASDAQ:AKRXAkorn Inc
13/03/202015:32Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AKRXAkorn Inc
26/02/202015:58GlobeNewswire Inc.Akorn Provides Fourth Quarter and Full Year 2019 ResultsNASDAQ:AKRXAkorn Inc
26/02/202015:51Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AKRXAkorn Inc
12/02/202016:29PR Newswire (US)Akorn Announces New Extension of Standstill with Lenders and Agrees to Pursue a Sale of its BusinessNASDAQ:AKRXAkorn Inc
10/02/202006:00PR Newswire (US)Akorn Continues Negotiations with LendersNASDAQ:AKRXAkorn Inc
16/12/201906:51GlobeNewswire Inc.Akorn Announces Extension of Standstill AgreementNASDAQ:AKRXAkorn Inc
05/11/201918:00GlobeNewswire Inc.Akorn to Present at the Credit Suisse Healthcare ConferenceNASDAQ:AKRXAkorn Inc
31/10/201906:00GlobeNewswire Inc.Akorn Provides Preliminary Third Quarter 2019 ResultsNASDAQ:AKRXAkorn Inc
14/10/201915:25GlobeNewswire Inc.Akorn Receives FDA Approval for Betamethasone Dipropionate Lotion USP (Augmented), 0.05%NASDAQ:AKRXAkorn Inc
14/10/201912:05GlobeNewswire Inc.Akorn to Report Third Quarter 2019 Financial Results and Host Conference CallNASDAQ:AKRXAkorn Inc
26/08/201915:10Edgar (US Regulatory)Application for Qualification of Trust Indentures (t-3)NASDAQ:AKRXAkorn Inc
26/08/201912:35GlobeNewswire Inc.Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.15%NASDAQ:AKRXAkorn Inc
02/08/201912:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AKRXAkorn Inc
01/08/201906:00GlobeNewswire Inc.Akorn Provides Preliminary Second Quarter 2019 ResultsNASDAQ:AKRXAkorn Inc
19/07/201916:11Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:AKRXAkorn Inc
11/07/201915:32GlobeNewswire Inc.Akorn to Report Second Quarter 2019 Financial Results and Host Conference CallNASDAQ:AKRXAkorn Inc
28/06/201906:00GlobeNewswire Inc.Akorn Announces Launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%NASDAQ:AKRXAkorn Inc
 Showing the most relevant articles for your search:NASDAQ:AKRX

Su Consulta Reciente

COIN
COPSETH
copsfinance.com
LSE
15QK
Barclays 33
BOV
BMGB4
BMG PN
ASX
SFP
Safety Medical Products
LSE
BR11
Bank Mont.34
USOTC
CVPUF
C P Seven Eleven Public (PK)
COIN
GOLDTKEUR
GOLDEN TOKEN
BIT
F14186
Vontobel Financial Produ...
KUCN
GARIUSDT
Gari Network
AMEX
SVI
Services Acquisition
USOTC
NTMFF
Neotech Metals (PK)
TG
FOT
Fortum
NASDAQ
APACU
StoneBridge Acquisition
USOTC
CHALF
Chalice Brands (CE)
EU
ILERN
RIZE LERN INAV
USOTC
CSFGF
China Success Financial (PK)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados